Skip to main content

Table 5 Multivariate Cox model analysis of negative conversion (day)

From: Thymalfasin therapy accelerates COVID-19 pneumonia rehabilitation through anti-inflammatory mechanisms

 

HR

Z value

P value

Use of Thymalfasin or not

1.40

2.58

0.01

Age (65 as the demarcation)

0.23

-7.74

0.00

Gender

1.06

0.58

0.56

WBC (10 as the demarcation)

0.85

-8.2

0.4

CRP (50 as the demarcation)

0.88

-1.03

0.3

PCT (0.05 as the demarcation)

0.92

-0.69

0.49

LYM (20% as the demarcation)

1.02

0.22

0.82

  1. Multivariate Cox model analysis showed that the use of Thymalfasin and younger patients were significant factors for quick negative conversion of COVID-19 antigen
Back to article page

Pneumonia

ISSN: 2200-6133

Contact us